H & C Chemists INC

H & C Chemists INC was paid $4K by Medicaid between Feb 2019 and Jan 2023, across 4 billing codes. Its largest line is J7507, Tacrolimus, immediate release, oral, 1 mg — 65% of everything it billed.

33Billing provider infoH & C CHEMISTS INC
NEW YORK, NY 10021

33aNPI1801187166assigned 04/21/2011

33bProvider typePharmacy

28Total paid$4K

24GClaims2,321

24DCodes billed4

24AFirst – last monthFeb 2019 – Jan 2023

Compared with peers

Next to other Pharmacy providers in New York

Rank by total paid#56 of 126

Median peer was paid$2K

This provider vs. median1.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	568	$60.71
2020	787	$968.76
2021	800	$2K
2022	147	$1K
2023	19	$0.00

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J7507	Tacrolimus, immediate release, oral, 1 mg	65%	583	541	$3K
J7517	Mycophenolate mofetil, oral, 250 mg	35%	403	378	$1K
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	0%	901	583	$0.00
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	0%	434	418	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGELWAN, STEVEN (SUPERVISING PHARMACIST)